Geriatric medicine is a subspecialty of internal medicine or family medicine that deals with the complex medical and psychosocial problems of older adults, and it is rapidly evolving into both a hospital-based specialty and a specialty concerned with community care. Geriatric medicine is a branch of medicine concerned with clinical, remedial, preventive, and social aspects of disorders usually among people aged 65 years and above. The geriatric population requires more palliative care and support as compared with younger adults due to reduced immunity of the geriatrics. Increasing chronic diseases among geriatrics and favorable government initiative toward geriatric care is driving demand for geriatric medicines worldwide.
The global geriatric medicines market report estimates the market size (Revenue USD million – 2014 to 2021) for key market segments based on the indication types (arthritis, cancer, cardiovascular, neurological, osteoporosis, respiratory, etc.), and therapeutic areas (analgesics, anticoagulants, antidiabetic, antihypertensive, antipsychotics, proton pump inhibitors, statins, etc.), and forecasts growth trends (CAGR% – 2017 to 2021).
The global geriatric medicines market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global geriatric medicines market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global geriatric medicines market and included in this report are Abbott Laboratories, Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Eli Lilly and Company, Novartis AG, Pfizer, Inc., Merck & Company Inc., GlaxoSmithKline plc and Sanofi S.A.